RedShiftBio Homepage

Next Generation
in Protein
Characterization

RedShiftBio provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality.

Structure

Aggregation

Quantitation

Similarity

stability

Detection of Pressure Induced Aggregation Using MMS App note

Detection of Pressure-Induced Aggregation Using Microfluidic Modulation Spectroscopy (MMS)

The ability to detect protein aggregation is important at all stages of drug development. Early detection of aggregation is most desirable to inform development decisions since aggregation can negatively affect the functionality of a protein.

Read Our Newest App Note

AQS³®pro

The Next Generation in Protein Characterization

The AQS³pro brings protein secondary structure measurement into every stage of the biopharmaceutical pipeline. The AQS3pro generates repeatable, automated measurements with high sensitivity in complex formulation conditions that are not possible with traditional analytical methods.